Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT04152837 · TERMINATED
Trial details
- NCT number
- NCT04152837
- Sponsor
- Palladio Biosciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2022-07-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.